Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Double Immunosuppression With or Without Anti-fibrotic in Scleroderma ILD

NCT07491523 is registered in ClinicalTrials.gov with University of Patras as lead sponsor.

NCT NCT07491523
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07491523 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Double Immunosuppression With or Without Anti-fibrotic in Scleroderma ILD
Lead sponsor
University of Patras
Phase
Observational
Overall status
Recruiting
Start date
June 1, 2025
Completion date
March 31, 2027
Enrollment
35 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

ssc-systemic sclerosis